Project Grant F31DA060004
- This $2.11 million Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research conducted by Pennsylvania State University's Milton S. Hershey Medical Center from May 2025 through February 2030. The award funds investigational research on cocaine addiction using an animal model to identify individual vulnerability to addiction early in disease development and to test early intervention strategies. The...
- This project grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports fundamental neuroscience research investigating the neural mechanisms linking stress exposure to opioid use disorder initiation. The University of South Carolina received $192,149 to conduct a two-year research project (February 1, 2026 through January 31, 2028) examining noradrenergic circuit mechanisms in stress-induced opioid-seeking behavior....
- The University of Washington was awarded a $149,284 Project Grant by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the role of specific subpopulations of prefrontal cortex pyramidal neurons in regulating drug-seeking behavior. The research aims to elucidate the factors that predispose individuals to addiction and confer vulnerability to relapse, with the goal of advancing understanding of the functional roles of...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $1,620,883 to The Regents of the University of California, San Francisco under the Drug Use and Addiction Research Programs (CFDA 93.279) for a project period from July 1, 2025, through March 31, 2030. The research project, titled "Network and Circuit Dynamics Supporting Dopaminergic Control of Sudden Insight Learning," focuses on understanding the brain mechanisms underlying abrupt behavioral...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded UCLA a $1.23 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 1, 2025, and concluding March 31, 2030. This award supports research investigating the neural circuit mechanisms linking dopaminergic (DA) reward prediction signaling and temporal processing in reinforcement learning. The project will deliver scientific research products through combined experimental and...
- This five-year, $573,638 project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, supports research into the neural mechanisms of individual differences in cocaine avoidance. Funded under the Drug Abuse and Addiction Research Programs (CFDA 93.279), the grant to the Medical University of South Carolina will examine cellular mechanisms by which serotonin and glutamate receptors in the rostromedial tegmental nucleus drive aversive conditioning...
- Federal Project Grant Award Summary New York University received a $390,687 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective August 1, 2025, with completion scheduled for April 30, 2030. This award supports neuroscience research investigating how multiregional brain interactions support value-based decision-making and belief updating relevant to addiction-related behaviors. The research focuses on characterizing...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $872,100 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 30, 2025 through May 31, 2030. The grant funds research titled "Dissecting and Modulating Cell Type and Circuit-Specific Epigenetic Mechanisms of Cocaine Addiction," which addresses the substantial public health burden of...
- Federal Project Grant Award Summary New York University has been awarded $201,250 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for a two-year project period from June 1, 2025, through May 31, 2027. This Project Grant supports basic neuroscience research investigating the synaptic organization of cholinergic interneurons in the nucleus accumbens, a brain region critical to motivated behaviors and implicated in substance use...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $877,500 Project Grant to the University of California, San Diego on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the neurobiological mechanisms underlying cocaine use disorder (CUD) susceptibility. The project, titled "Enhancing Addiction Severity Prediction by Modulating GABAergic Activity in the Central Amygdala of Rattaca Rats," will operate through...
CHARACTERIZING BLA DOPAMINERGIC AND GLUTAMATERGIC MECHANISMS OF DYNAMIC DRUG SEEKING - PROJECT SUMMARY RELAPSE AND CRAVING IN ADDICTION ARE HEAVILY CONTROLLED BY ENVIRONMENTAL CUES THAT EVOKE DYNAMIC MOTIVATIONAL STATES AND REINFORCE ACTIONS. BOTH THE BASOLATERAL AMYGDALA (BLA) AND DOPAMINE (DA) SIGNALING ARE CRITICAL FOR ASSOCIATIVE LEARNING PROCESSES AND CUE-DRIVEN MOTIVATIONAL STATES. THE BLA RECEIVES DENSE DOPAMINERGIC PROJECTIONS AND IS ENRICHED WITH D1 DA RECEPTORS (D1DRS), HOWEVER BLA DA FUNCTIONS IN ADDICTION REMAIN LARGELY UNEXPLORED. PRESENTATIONS OF COCAINE-PREDICTIVE STIMULI INCREASE EXTRACELLULAR DA LEVELS AND ACTIVATE NEURONS WITHIN THE AMYGDALA, WHILE BLA D1DRS INFLUENCE DRUG-SEEKING BEHAVIORS AND THEIR ACTIVATION INCREASES EXCITABILITY OF BLA PRINCIPAL NEURONS - A MAJOR TARGET OF DA INPUTS INTO THE BLA. AS THERE ARE EXTENSIVE EXCITATORY PROJECTIONS FROM THE BLA TO THE NUCLEUS ACCUMBENS (NAC), IF BLA DA AND D1-NEURONS ARE UNDERLYING FACETS OF STATE DYNAMICS-DRIVEN DRUG SEEKING BEHAVIORS, SYNAPTIC STRENGTH WITHIN THIS PATHWAY MAY BE UNIQUELY POTENTIATED FOLLOWING BINGE-LIKE COCAINE SEEKING. UNDERSTANDING THE ROLE OF BLA ACTIVITY AND DA SIGNALING IN DRUG SEEKING WILL REVEAL NOVEL INSIGHT INTO THE BRAIN CIRCUITRY THAT DRIVES EMOTIONAL LEARNING AND ADDICTION-RELATED BEHAVIORS TO PROVIDE A STRONG SCIENTIFIC FRAMEWORK FOR INVESTIGATING MECHANISMS UNDERLYING AFFECTIVE DISEASES. THIS PROPOSAL WILL MAKE USE OF NEW TOOLS TO RECORD AND MANIPULATE DA AND D1 NEURONS IN THE AMYGDALA TO INVESTIGATE THEIR CONTRIBUTIONS TO DYNAMIC COCAINE SEEKING BEHAVIORS (AIM 1) AND INVESTIGATE HOW BINGE-LIKE COCAINE SELF-ADMINISTRATION IMPACTS THE FUNCTIONAL CONNECTIVITY OF GLUTAMATERGIC BLA TO NAC CIRCUITS (AIM 2). FIRST, I WILL MEASURE IN VIVO DA SIGNALING AND D1-NEURON ACTIVITY IN THE BLA DURING COCAINE SELF-ADMINISTRATION USING FIBER PHOTOMETRY TO TEST THE HYPOTHESIS THAT BLA DA TRANSMISSION AND D1-NEURON ACTIVITY WILL TRACK THE EMERGENCE OF DYNAMIC, SENSORY-GUIDED DRUG SEEKING MOTIVATIONAL STATES. I WILL ALSO OPTOGENETICALLY INHIBIT BLA D1-NEURONS DURING THE SAME PARADIGM TO INVESTIGATE IF BLA D1-NEURONS PLAY A NECESSARY ROLE IN STATE-LEVEL CONTROL OF BINGE-LIKE DRUG SEEKING. FINALLY, IN AN EX VIVO PREPARATION, I WILL USE OPTOGENETICS TO STIMULATE THE TERMINALS OF GLUTAMATERGIC BLA PROJECTION NEURONS IN AN NAC SLICE WHILE RECORDING THE RESULTING LOCAL FIELD POTENTIALS AFTER RATS UNDERGO COCAINE SELF-ADMINISTRATION. THESE STUDIES WILL TEST THE HYPOTHESIS THAT BLA-NAC EXCITATORY SYNAPTIC STRENGTH WILL BE MODULATED BY THE PATTERN OF DRUG USE HISTORY VIA DRUG STATE-INTERMITTENCY INFORMATION FROM THE BLA. THIS PROPOSAL WILL ESTABLISH FUNDAMENTAL PRINCIPLES BY WHICH DOPAMINERGIC AND GLUTAMATERGIC MECHANISMS INTERACT WITHIN THE AMYGDALOSTRIATAL SYSTEM TO INFLUENCE THE EMERGENCE AND CONTROL OF DYNAMIC DRUG-SEEKING MOTIVATIONAL STATES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $576 | 3/24/26 | ||
| Not listed | $49.5k | 1/28/26 | ||
| Not listed | $49.5k | 1/28/26 | ||
| Not listed | $564 | 8/11/25 | ||
| Not listed | $564 | 8/11/25 |